Skip to content

Effect of intralesional Mitomycin-C and Triamcinolone on reducing the urethral stricture recurrence

Comparison between the effect of intralesional Mitomycin-C and Triamcinolone on reducing the urethral stricture recurrence in patients undergoing internal urethrotomy surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201006048950N4
Enrollment
100
Registered
2024-03-04
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urethral stricture.

Interventions

Intervention 1: Intervention group: The rate of recurrence of urethral stricture. Intervention 2: Control group: The rate of recurrence of urethral stricture.

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: The gender is male. have Bulbomembranous or a history of it History of radiotherapy History of radical prostatectomy and open prostatectomy

Exclusion criteria

Exclusion criteria: Have a history of once or twice internal ureterotomy Suffering from cancer of the prostate, bladder and urethra Urethral stricture more than 15 mm Suffering from BXO (Balinitis xerotica Obliterans) Have a history of straddle injury

Design outcomes

Primary

MeasureTime frame
Comparison between the effect of intralesional Mitomycin-C and Triamcinolone on reducing the urethral stricture recurrence in patients undergoing internal urethrotomy surgery. Timepoint: The injection of Mitomycin C and Triamcinolone are injected into the urethra in groups in five sessions. These injections are given daily in the first week, every other day in the second week, and then twice a week for two months. Method of measurement: After the interventions, the symptoms of Urethral Sound Dilator (USD) in patients will be evaluated based on the QoL (Quality of life) and IPSS (The International Prostate Symptom Score) questionnaires, as well as uroflowmetry test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasoul Jafari

Arak University of Medical Sciences

amozesh@arakmu.ac.ir+98 86 3383 8602

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026